Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Marginal zone lymphomas: factors that affect the final outcome.

Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS.

Cancer. 2010 Sep 15;116(18):4291-8. doi: 10.1002/cncr.25325.

2.

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Sarris AH, Dang NH, Wang M, Beasley V, Medeiros LJ, Katz RL, Gagneja H, Samuels BI, Smith TL, Cabanillas FF.

J Clin Oncol. 2005 Oct 1;23(28):7013-23. Epub 2005 Sep 6. Erratum in: J Clin Oncol. 2006 Feb 1;24(4):724.

PMID:
16145068
3.

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.

Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F.

Clin Cancer Res. 2004 Aug 15;10(16):5432-8.

4.

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.

Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, Korbling M, Younes A, Ippoliti C, Gajewski JL, McLaughlin P, Anderlini P, Donato ML, Cabanillas FF, Champlin RE.

Blood. 2001 Dec 15;98(13):3595-9.

5.

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B, Giralt S, Gajewski J, de Lima M, Couriel D, Romaguera J, Cabanillas FF, Champlin RE, Khouri IF.

J Clin Oncol. 2001 Sep 1;19(17):3766-70.

PMID:
11533100
6.

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

Wilder RB, Rodriguez MA, Tucker SL, Ha CS, Hess MA, Cabanillas FF, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):743-9.

PMID:
11395243
7.

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

Pelloski CE, Wilder RB, Ha CS, Hess MA, Cabanillas FF, Cox JD.

Radiother Oncol. 2001 May;59(2):145-51.

PMID:
11325442
8.

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):17-22.

PMID:
11163493
9.

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.

Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1107-10.

PMID:
11072169
10.

Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.

Katz RL, Caraway NP, Gu J, Jiang F, Pasco-Miller LA, Glassman AB, Luthra R, Hayes KJ, Romaguera JE, Cabanillas FF, Medeiros LJ.

Am J Clin Pathol. 2000 Aug;114(2):248-57.

PMID:
10941340
11.

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.

Thomas DA, Cortes J, O'Brien S, Pierce S, Faderl S, Albitar M, Hagemeister FB, Cabanillas FF, Murphy S, Keating MJ, Kantarjian H.

J Clin Oncol. 1999 Aug;17(8):2461-70.

PMID:
10561310
12.

Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).

Luthra R, Sarris AH, Hai S, Paladugu AV, Romaguera JE, Cabanillas FF, Medeiros LJ.

Am J Clin Pathol. 1999 Oct;112(4):524-30.

PMID:
10510675
13.

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.

Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF.

Ann Intern Med. 1999 Jul 20;131(2):88-95.

PMID:
10419446
14.

Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.

Ha CS, Kavadi V, Dimopoulos MA, Hagemeister FB, Osborne BM, Fuller LM, Smith TL, Hess MA, McLaughlin PW, Cabanillas FF, Cox JD.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):329-34.

PMID:
10030257
15.

Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.

Maor MH, North LB, Cabanillas FF, Ames AL, Hess MA, Cox JD.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):647-50.

PMID:
9635715
16.

Fine-needle aspiration cytology of mediastinal non-Hodgkin's nonlymphoblastic lymphoma.

Hughes JH, Katz RL, Fonseca GA, Cabanillas FF.

Cancer. 1998 Feb 25;84(1):26-35.

PMID:
9500649
17.

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.

Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P, Romaguera JE, Cabanillas FF, Ha CS, Lipshultz LI, Hagemeister FB.

J Clin Oncol. 1997 Dec;15(12):3488-95.

PMID:
9396402
18.

Combined modality therapy for cutaneous T-cell lymphoma.

Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R.

J Am Acad Dermatol. 1996 Jun;34(6):1022-9. Erratum in: J Am Acad Dermatol 1996 Oct;35(4):587.

PMID:
8647968
19.

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

van Besien KW, Mehra RC, Giralt SA, Kantarjian HM, Pugh WC, Khouri IF, Moon Y, Williams P, Andersson BS, Przepiorka D, McCarthy PL, Gajewski JL, Deisseroth AB, Cabanillas FF, Champlin R.

Am J Med. 1996 Mar;100(3):299-307.

PMID:
8629675
20.

Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.

Stroh EL, Besa PC, Cox JD, Fuller LM, Cabanillas FF.

Cancer. 1995 May 1;75(9):2392-9.

PMID:
7712450
21.

Multicentric Castleman's disease.

Herrada J, Cabanillas FF.

Am J Clin Oncol. 1995 Apr;18(2):180-3. No abstract available.

PMID:
7900713
22.

Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.

Velasquez WS, McLaughlin P, Fuller LM, Allen PK, Tucker SL, Swan F Jr, Rodriguez MA, Hagemeister FB, Cabanillas FF.

Cancer. 1994 May 1;73(9):2408-16.

PMID:
7513251
23.

A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.

Liang JC, Bailey NM, Gabriel GJ, Kattan MW, Wang RY, Hagemeister FB, Cabanillas FF, Fuller LM.

Leuk Lymphoma. 1993 Apr;9(6):503-8.

PMID:
7687918
24.

A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.

Rolston KV, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L.

Arch Intern Med. 1992 Feb;152(2):283-91.

PMID:
1739355
25.

Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia.

Sneige N, Dekmezian RH, Katz RL, Fanning TV, Lukeman JL, OrdoƱez NF, Cabanillas FF.

Acta Cytol. 1990 May-Jun;34(3):311-22.

PMID:
2111624
26.

Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

Taylor KM, Jagannath S, Spitzer G, Spinolo JA, Tucker SL, Fogel B, Cabanillas FF, Hagemeister FB, Souza LM.

J Clin Oncol. 1989 Dec;7(12):1791-9. Erratum in: J Clin Oncol 1990 Mar;8(3):567.

PMID:
2479719
27.

Management of patients with low-grade follicular lymphoma.

Cabanillas FF.

Am J Clin Oncol. 1989 Feb;12(1):81-7. No abstract available.

PMID:
2463754
28.

Reporting outcomes in Hodgkin's disease and lymphoma.

Dixon DO, McLaughlin P, Hagemeister FB, Freireich EJ, Fuller LM, Cabanillas FF, Gehan EA.

J Clin Oncol. 1987 Oct;5(10):1670-2. No abstract available.

PMID:
3655864
29.

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.

Jagannath S, Dicke KA, Armitage JO, Cabanillas FF, Horwitz LJ, Vellekoop L, Zander AR, Spitzer G.

Ann Intern Med. 1986 Feb;104(2):163-8.

PMID:
3511811
30.

Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.

Kantarjian HM, McLaughlin P, Fuller LM, Dixon DO, Osborne BM, Cabanillas FF.

J Clin Oncol. 1984 Jul;2(7):811-9.

PMID:
6376721
31.

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.

da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, McLaughlin P, Riggs SA, Cabanillas FF, Salvador PG.

J Clin Oncol. 1984 Jun;2(6):571-7.

PMID:
6547167
32.

Post-therapy CT-detected mass in lymphoma patients: is it viable tissue?

Lewis E, Bernardino ME, Salvador PG, Cabanillas FF, Barnes PA, Thomas JL.

J Comput Assist Tomogr. 1982 Aug;6(4):792-5.

PMID:
7119200
33.

Phase I trial of pentamethylmelamine.

Ajani JA, Cabanillas FF, Bodey GP.

Cancer Treat Rep. 1982 May;66(5):1227-8.

PMID:
6805950
34.

Percutaneous needle biopsy in abdominal lymphoma.

Zornoza J, Cabanillas FF, Altoff TM, Ordonez N, Cohen MA.

AJR Am J Roentgenol. 1981 Jan;136(1):97-103.

PMID:
6779586
35.

Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.

Mavlight GM, Stuckey SE, Cabanillas FF, Keating MJ, Tourtellotte WW, Schold SC, Freireich EJ.

N Engl J Med. 1980 Sep 25;303(13):718-22.

PMID:
6157089

Supplemental Content

Loading ...
Support Center